G. Bravi

发表

Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitors.

S. Ekins, G. Bravi, S. Binkley, 1999, The Journal of pharmacology and experimental therapeutics.

ADMET rules of thumb II: A comparison of the effects of common substituents on a range of ADMET parameters.

Daniel M. Lowe, Gianpaolo Bravi, Sandeep Modi, 2009, Bioorganic & medicinal chemistry.

Three-dimensional-quantitative structure activity relationship analysis of cytochrome P-450 3A4 substrates.

S. Ekins, G. Bravi, J. Wikel, 1999, The Journal of pharmacology and experimental therapeutics.

Three- and four-dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2C9 inhibitors.

S. Ekins, G. Bravi, S. Binkley, 2000, Drug metabolism and disposition: the biological fate of chemicals.

Modelling Structure‐Activity Relationships

Darren V. S. Green, Emanuela Gancia, Gianpaolo Bravi, 2000 .

A Comparison of Field‐Based Similarity Searching Methods: CatShape, FBSS, and ROCS.

Andrew R. Leach, Martin Whittle, Valerie J. Gillet, 2008 .

On the role of the molecular electrostatic potential in modelling the activity of non-peptide angiotensin II receptor antagonists

Anna Vulpetti, Carlo Scolastico, Gianpaolo Bravi, 1993 .

The Role of the Molecular Electrostatic Potential in Modeling the Activity of Non-Peptide Angiotensin II Receptor Antagonists

G. Bravi, L. Belvisi, A. Vulpetti, 1993 .

Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidate.

David Haigh, Malcolm Ellis, George Burton, 2007, Journal of medicinal chemistry.

Discovery of biaryl inhibitors of H+/K+ ATPase.

G. Bravi, E. Demont, M. Bamford, 2010, Bioorganic & medicinal chemistry letters.

Nonpeptide angiotensin II receptor antagonists. Synthesis, in vitro activity, and molecular modeling studies of N-[(heterobiaryl)methyl] imidazoles.

G. Bravi, L. Belvisi, R. Canevotti, 1994, Journal of medicinal chemistry.

Substrate recognition by ribosome-inactivating protein studied by molecular modeling and molecular electrostatic potentials.

G. Bravi, G. Legname, A. K. Chan, 1995, Journal of molecular graphics.

A Comparison of Field-Based Similarity Searching Methods: CatShape, FBSS, and ROCS

Valerie J Gillet, Gianpaolo Bravi, Martin Whittle, 2008, J. Chem. Inf. Model..

A comparison of the pharmacophore identification programs: Catalyst, DISCO and GASP

Andrew R. Leach, Valerie J. Gillet, Gianpaolo Bravi, 2002, J. Comput. Aided Mol. Des..

PLUMS: a Program for the Rapid Optimization of Focused Libraries

Darren V. S. Green, Andrew R. Leach, Gianpaolo Bravi, 2000, J. Chem. Inf. Comput. Sci..

Discovery of 3-oxabicyclo[4.1.0]heptane, a non-nitrogen containing morpholine isostere, and its application in novel inhibitors of the PI3K-AKT-mTOR pathway.

G. Bravi, M. Convery, H. Hobbs, 2019, Journal of medicinal chemistry.

Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors.

S. Ekins, G. Bravi, S. Binkley, 1999, Pharmacogenetics.

The reduced graph descriptor in virtual screening and data-driven clustering of high-throughput screening data.

G. Harper, G. S. Bravi, S. D. Pickett, 2004, Journal of chemical information and computer sciences.

Three-Dimensional-Quantitative Structure Activity Relationship Analysis of Cytochrome P-450 3 A 4 Substrates

S. Ekins, G. Bravi, J. Wikel, 1999 .

Lead Optimization Using Matched Molecular Pairs: Inclusion of Contextual Information for Enhanced Prediction of hERG Inhibition, Solubility, and Lipophilicity

Visakan Kadirkamanathan, George Papadatos, Peter Willett, 2010, J. Chem. Inf. Model..

A 3D QSAR CoMFA study of non-peptide angiotensin II receptor antagonists

Carlo Scolastico, Gianpaolo Bravi, Laura Belvisi, 1996, J. Comput. Aided Mol. Des..

A 3D QSAR approach to the search for geometrical similarity in a series of nonpeptide angiotensin II receptor antagonists

Roberto Todeschini, Anna Vulpetti, Carlo Scolastico, 1994, J. Comput. Aided Mol. Des..

Three-dimensional quantitative structure activity relationship analyses of substrates for CYP2B6.

S. Ekins, G. Bravi, J. Gillespie, 1999, The Journal of pharmacology and experimental therapeutics.

Three-Dimensional Quantitative Structure Activity Relationship Analyses of Substrates for CYP 2 B 6

S. Ekins, G. Bravi, J. Gillespie, 1998 .

MS-WHIM, new 3D theoretical descriptors derived from molecular surface properties: A comparative 3D QSAR study in a series of steroids

Roberto Todeschini, Andrea Zaliani, Emanuela Gancia, 1997, J. Comput. Aided Mol. Des..

The Reduced Graph Descriptor in Virtual Screening and Data-Driven Clustering of High-Throughput Screening Data

Darren V. S. Green, Gavin Harper, Stephen D. Pickett, 2005, J. Chem. Inf. Model..

SONHICA (Simple optimized non‐HIerarchical Cluster Analysis): A new tool for analysis of molecular conformations

Emanuela Gancia, Gianpaolo Bravi, Monica Pegna, 1997 .

A comparison of the pharmacophore identification programs: Catalyst, DISCO and GASP

A. Leach, V. Gillet, G. Bravi, 2002, J. Comput. Aided Mol. Des..